-
Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart DiseaseF Khan, T Okuno, D Malebranche et al. -
Cardiac surgery following transcatheter aortic valve replacementS Saha, S Peterss, C Mueller et al.
-
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNM Van Mieghem, M Unverdorben, the ENVISAGE-TAVI AF Investigators.
-
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJ Butler, G Filippatos, TJ Siddiqi et al.
-
Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology/American Heart Association Guidelines for Management of Valvular Heart DiseaseTM Sundt; H Jneid et al.
-
Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic StenosisB Tamarappoo, D Han, D Berman et al.
-
Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart AssociationGR Shroff , S Bangalore and On behalf of the American Heart Association Council on the Kidney in Cardiovascular Disease and Stroke Council
-
Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral AnticoagulantsM Brinkert, N Mangner, S Toggweiler et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
